US Broker Ratings

ICON plc (ICLR) Stock Analysis: Unpacking a 9.6% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading clinical research organization, stands at an intriguing juncture for investors seeking exposure in the healthcare sector. With a market capitalization of $13.06 billion, the..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 31% Upside Potential Amid Healthcare Innovation

Koninklijke Philips N.V. (NYSE: PHG), a Dutch healthcare technology leader, presents a compelling opportunity for investors with a potential upside of nearly 31% based on current analyst ratings. Operating at..

Teleflex Incorporated (TFX) Stock Analysis: A 17.22% Potential Upside Amidst Strong Revenue Growth

Investors eyeing opportunities in the healthcare sector may find Teleflex Incorporated (NYSE: TFX) an intriguing option, especially with an enticing potential upside of 17.22% based on current analyst targets. This..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 10.20% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, operates within the Diagnostics & Research industry and boasts a market capitalization of $25.27 billion. The company’s current..

Quest Diagnostics (DGX): Investor Outlook Highlights 4.98% Potential Upside

As investors navigate the intricate landscape of healthcare equities, Quest Diagnostics Incorporated (NYSE: DGX) emerges as a noteworthy consideration. With its roots entrenched in the diagnostics and research industry, Quest..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Promising 89% Upside Potential in the Biotech Sector

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology industry, is capturing investor attention with its compelling growth story and substantial upside potential. Based in Australia, Telix is..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 9.23% Potential Upside with Strategic Collaborations

Biogen Inc. (NASDAQ: BIIB) remains a captivating prospect for investors seeking exposure in the healthcare sector, particularly within the pharmaceutical landscape. With its strategic focus on cutting-edge therapies and robust..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings and 14% Upside Potential

For investors eyeing opportunities in the healthcare sector, Danaher Corporation (NYSE: DHR) presents a compelling proposition. With its robust $140.7 billion market cap, Danaher stands as a titan in the..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating a 33.64% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Silver Spring, Maryland, the company..

Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings and a 14.85% Upside Potential

Cencora, Inc. (COR), a healthcare titan in the medical distribution industry, continues to capture investor attention with its robust market presence and promising growth prospects. With a market capitalization of..

Insulet Corporation (PODD) Stock Analysis: Eyeing a 30% Upside Amid Strong Revenue Growth

Investors with a keen eye on the healthcare sector may find Insulet Corporation (NASDAQ: PODD) an intriguing prospect, especially given its current market position and potential upside. With a robust..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Robust Growth in Healthcare Diagnostics with a 5.54% Upside Potential

IQVIA Holdings, Inc. (NYSE: IQV) continues to make compelling strides in the healthcare sector, showcasing a promising trajectory for investors seeking exposure to the diagnostics and research industry. With a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 12.99% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the global pharmaceutical landscape, stands at an intriguing juncture for investors. Established in 1901 and headquartered in Tel Aviv-Yafo, Israel,..

Abbott Laboratories (ABT) Investor Outlook: Strong Buy Ratings and 18% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare and medical devices industry, presents a compelling opportunity for investors seeking growth and stability. With a market capitalization of $176.41 billion,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 25.36% Potential Upside in the Healthcare Giant

UnitedHealth Group Incorporated (NYSE: UNH) stands as a behemoth in the healthcare industry with a market capitalization of $340.27 billion. As a leader in healthcare plans, UnitedHealth Group offers a..

Waystar Holding Corp. (WAY) Stock Analysis: A Strong Buy with 41.9% Upside Potential

For investors seeking opportunities in the healthcare technology sector, Waystar Holding Corp. (NASDAQ: WAY) presents itself as a compelling option. With a significant potential upside of 41.9% based on analyst..

Repligen Corporation (RGEN) Stock Analysis: Strong Buy Ratings and 14.71% Upside Potential

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in medical instruments and supplies, specifically focusing on bioprocessing technologies. With a market capitalization of $9.32 billion and..

BeOne Medicines Ltd. (ONC): Investor Outlook Reveals 24.8% Potential Upside in Biotechnology Giant

BeOne Medicines Ltd. (ONC), a Switzerland-based biotechnology powerhouse, has garnered significant investor attention with a promising outlook underscored by a potential upside of 24.8%. As a pivotal player in the..

Novartis AG (NVS) Stock Analysis: Evaluating a 14% Potential Upside and Robust Dividend Yield

Novartis AG (NYSE: NVS), a heavyweight in the global pharmaceutical industry, has consistently been a focal point for investors seeking stability and growth in the healthcare sector. Headquartered in Basel,..

Illumina, Inc. (ILMN) Stock Analysis: Exploring Growth Potential Amidst a 32.34% ROE

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector’s Diagnostics & Research industry, has been capturing investor attention with its robust offerings in genetic and genomic analysis solutions. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds